Home > Result Summaries: Compounds > Hepatitis B Vaccine, Recombinant > Result Summary for 103967

Result Summary for 103967

Result Summary

Protocol ID:	103967
Clinical Study ID:	103967
Official Title:	A Phase I/IIb randomized, double-blind, controlled study of the safety, immunogenicity and proof-of-concept of RTS,S/AS02D, a candidate malaria vaccine in infants living in a malaria-endemic region
Phase:	phase 2
Study Indications or Diseases:	Hepatitis B
Generic Name:	Hepatitis B Vaccine, Recombinant
Trade/Product Name:	Engerix-B
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Aponte JJ et al. (2007) Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 370 (9598):1543-1551. Aide Pedro et al. (2010) Safety, immunogenicity and duration of protection of the RTS,S/AS02D malaria vaccine: One year follow-up of a randomized controlled phase I/IIb trial. Plos One. 5(11): e13838.